Dr Cao is a technology entrepreneur founded BioNano Genomics, as a spin out of Nanostructure Lab at Electrical Engineering Department of the Princeton University where he was working on a multimillion dollar project funded by the U.S. Defense Advanced Research Projects Agency (DARPA). Dr. Cao is the key co-inventor of the company's core single-molecule nanoscale whole genome analysis technology, he obtained over $10 M funding from multiple federal government agencies to commercialize the platform technology at BioNano Genomics and has served on many special contracts and grant review panels. BioNano Genomics has grown from a single person company to the stage of commercial products launched and installed on 4 continents with revenue. He oversees the scientific and technical direction of future applications, technology and product development at BioNano Genomics.
Prior to that, Dr Cao was a postdoctoral fellow at the Institute for Human Gene Therapy of University of Pennsylvania Medical Center working on stem cell and DNA repair system projects. His diverse experience includes molecular biology, high throughput industrial microarray and genomics technology development, single-molecule analysis as well as micro and nanofluidics design and fabrication. Dr. Cao received a B.S. degree from the University of Science and Technology of China and a Ph.D. in molecular biology from the University of Delaware.